封面
市场调查报告书
商品编码
1417998

智慧胰岛素贴片市场报告:2030 年趋势、预测与竞争分析

Smart Insulin Patch Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

智慧胰岛素贴片趋势与预测

预计 2024 年至 2030 年,全球智慧胰岛素贴片市场将以 5.6% 的复合年增长率成长。该市场的主要驱动力是对便利性、个人化糖尿病管理解决方案的需求不断增长,以及穿戴式科技和医疗保健创新的进步。全球智慧胰岛素贴片市场前景广阔,第1型糖尿病市场和第2型糖尿病市场充满机会。

智慧胰岛素贴片市场洞察

Lucintel 预测,由于全面的Bolus管理涵盖了Bolus和推注胰岛素需求,基础推注胰岛素将在预测期内实现最高增长。

由于其高盛行率和广泛的患者群体,2 型糖尿病将继续成为该市场的最大细分市场。

由于其先进的医疗基础设施和高糖尿病盛行率,预计北美在预测期内将出现最高的增长。

常问问题

Q1.市场成长预测如何?

A1. 2024年至2030年,全球智慧胰岛素贴片市场预计将以5.6%的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些?

A2. 该市场的主要驱动力是对便利性和个人化糖尿病管理解决方案的需求不断增长、可穿戴技术的进步和医疗保健创新。

Q3.市场的主要细分市场有哪些?

A3. 由于第1型糖尿病和2型糖尿病市场的机会,智慧胰岛素贴片市场的未来性广阔。

Q4.市场上主要企业有哪些?

A4. 主要的智慧胰岛素贴片公司如下。

  • Cequr
  • Zenomics
  • Medtronic
  • Abbott Laboratories
  • Dexcom

Q5.未来最大的细分市场是什么?

A5.Lucintel 预计将在预测期内表现出最高的成长,因为其全面的糖尿病管理涵盖了基础和Bolus胰岛素需求。

Q6. 未来五年预计哪个地区将成为最大的市场?

A6. 由于其先进的医疗基础设施和高糖尿病盛行率,预计北美在预测期内将出现最高的增长。

Q7. 可以客製化报告吗?

A7. 是的,Lucintel 提供 10% 的客製化服务,无需额外费用。

目录

第一章执行摘要

第二章全球智慧型胰岛素贴片市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球智慧型胰岛素贴片市场趋势(2018-2023)与预测(2024-2030)
  • 全球智慧型胰岛素贴片市场,按类型
    • 基础胰岛素
    • Bolus胰岛素
    • 基础Bolus胰岛素
  • 全球智慧型胰岛素贴片市场(按应用)
    • 1型糖尿病
    • 2型糖尿病

第四章 2018-2030年区域市场趋势及预测分析

  • 全球智慧型胰岛素贴片市场(按地区)
  • 北美智慧型胰岛素贴片市场
  • 欧洲智慧型胰岛素贴片市场
  • 亚太地区智慧胰岛素贴片市场
  • 其他地区智慧型胰岛素贴片市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球智慧胰岛素贴片市场成长机会
    • 全球智慧型胰岛素贴片市场成长机会(按应用)
    • 全球智慧型胰岛素贴片市场成长机会(按地区)
  • 全球智慧胰岛素贴片市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球智慧胰岛素贴片市场产能扩张
    • 全球智慧胰岛素贴片市场的併购与合资
    • 认证和许可

第七章主要企业概况

  • CeQur
  • Zenomics
  • Medtronic
  • Abbott Laboratories
  • Dexcom
简介目录

Smart Insulin Patch Trends and Forecast

The future of the global smart insulin patch market looks promising with opportunities in the type 1 diabetes and type 2 diabetes markets. The global smart insulin patch market is expected to grow with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing demand for convenient and personalized diabetes management solutions and advancements in wearable technology and healthcare innovation.

A more than 150-page report is developed to help in your business decisions.

Smart Insulin Patch by Segment

The study includes a forecast for the global smart insulin patch by type, application, and region.

Smart Insulin Patch Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Basal Insulin
  • Bolus Insulin
  • Basal-Bolus Insulin

Smart Insulin Patch Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Type 1 Diabetes
  • Type 2 Diabetes

Smart Insulin Patch Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Smart Insulin Patch Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies smart insulin patch companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the smart insulin patch companies profiled in this report include-

  • Cequr
  • Zenomics
  • Medtronic
  • Abbott Laboratories
  • Dexcom

Smart Insulin Patch Market Insights

Lucintel forecasts that basal-bolus insulin is expected to witness highest growth over the forecast period due to comprehensive diabetes management, covering both basal and bolus needs.

Within this market, type 2 diabetes will remain the largest segment due to its higher prevalence and broader patient base.

North America is expected to witness highest growth over the forecast period due to advanced healthcare infrastructure and high diabetes prevalenc.

Features of the Global Smart Insulin Patch Market

Market Size Estimates: Smart insulin patch market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Smart insulin patch market size by type, application, and region in terms of value ($B).

Regional Analysis: Smart insulin patch market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the smart insulin patch market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the smart insulin patch market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for smart insulin patch market?

Answer: The global smart insulin patch market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the smart insulin patch market?

Answer: The major drivers for this market are increasing demand for convenient and personalized diabetes management solutions and advancements in wearable technology and healthcare innovation.

Q3. What are the major segments for smart insulin patch market?

Answer: The future of the smart insulin patch market looks promising with opportunities in the type 1 diabetes and type 2 diabetes markets.

Q4. Who are the key smart insulin patch market companies?

Answer: Some of the key smart insulin patch companies are as follows.

  • Cequr
  • Zenomics
  • Medtronic
  • Abbott Laboratories
  • Dexcom

Q5. Which smart insulin patch market segment will be the largest in future?

Answer: Lucintel forecasts that basal-bolus insulin is expected to witness highest growth over the forecast period due to comprehensive diabetes management, covering both basal and bolus needs.

Q6. In smart insulin patch market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to advanced healthcare infrastructure and high diabetes prevalenc.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the smart insulin patch market by type (basal insulin, bolus insulin, and basal-bolus insulin), application (type 1 diabetes and type 2 diabetes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Smart Insulin Patch Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Smart Insulin Patch Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Smart Insulin Patch Market by Type
    • 3.3.1: Basal Insulin
    • 3.3.2: Bolus Insulin
    • 3.3.3: Basal-Bolus Insulin
  • 3.4: Global Smart Insulin Patch Market by Application
    • 3.4.1: Type 1 Diabetes
    • 3.4.2: Type 2 Diabetes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Smart Insulin Patch Market by Region
  • 4.2: North American Smart Insulin Patch Market
    • 4.2.2: North American Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
  • 4.3: European Smart Insulin Patch Market
    • 4.3.1: European Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
    • 4.3.2: European Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
  • 4.4: APAC Smart Insulin Patch Market
    • 4.4.1: APAC Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
    • 4.4.2: APAC Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes
  • 4.5: ROW Smart Insulin Patch Market
    • 4.5.1: ROW Smart Insulin Patch Market by Type: Basal Insulin, Bolus Insulin, and Basal-Bolus Insulin
    • 4.5.2: ROW Smart Insulin Patch Market by Application: Type 1 Diabetes, and Type 2 Diabetes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Smart Insulin Patch Market by Type
    • 6.1.2: Growth Opportunities for the Global Smart Insulin Patch Market by Application
    • 6.1.3: Growth Opportunities for the Global Smart Insulin Patch Market by Region
  • 6.2: Emerging Trends in the Global Smart Insulin Patch Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Smart Insulin Patch Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Smart Insulin Patch Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CeQur
  • 7.2: Zenomics
  • 7.3: Medtronic
  • 7.4: Abbott Laboratories
  • 7.5: Dexcom